Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM
NCT01804842
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
Met DR
Sponsor
Elcelyx Therapeutics, Inc.